154 related articles for article (PubMed ID: 30680234)
1. Role of percutaneous nephrostomy in end of life prostate cancer patients: a systematic review of the literature.
New F; Deverill S; Somani BK
Cent European J Urol; 2018; 71(4):404-409. PubMed ID: 30680234
[TBL] [Abstract][Full Text] [Related]
2. Outcomes Related to Percutaneous Nephrostomies (PCN) in Malignancy-Associated Ureteric Obstruction: A Systematic Review of the Literature.
New FJ; Deverill SJ; Somani BK
J Clin Med; 2021 May; 10(11):. PubMed ID: 34072127
[TBL] [Abstract][Full Text] [Related]
3. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right?
Misra S; Coker C; Richenberg J
Int Urol Nephrol; 2013 Jun; 45(3):627-32. PubMed ID: 23666587
[TBL] [Abstract][Full Text] [Related]
5. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.
ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H
BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195
[TBL] [Abstract][Full Text] [Related]
6. Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer.
Nariculam J; Murphy DG; Jenner C; Sellars N; Gwyther S; Gordon SG; Swinn MJ
Br J Radiol; 2009 Jul; 82(979):571-6. PubMed ID: 19153185
[TBL] [Abstract][Full Text] [Related]
7. Clinical Factors Associated With a Short Survival Time After Percutaneous Nephrostomy for Ureteric Obstruction in Cancer Patients: An Updated Model.
Alawneh A; Tuqan W; Innabi A; Al-Nimer Y; Azzouqah O; Rimawi D; Taqash A; Elkhatib M; Klepstad P
J Pain Symptom Manage; 2016 Feb; 51(2):255-61. PubMed ID: 26497918
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous nephrostomy in obstructing pelvic malignancy does not facilitate further oncological treatment.
Folkard SS; Banerjee S; Menzies-Wilson R; Reason J; Psallidas E; Clissold E; Al-Mushatat A; Chaudhri S; Green JSA
Int Urol Nephrol; 2020 Sep; 52(9):1625-1628. PubMed ID: 32319003
[TBL] [Abstract][Full Text] [Related]
9. Nephrostomy tube or 'JJ' ureteric stent in ureteric obstruction: assessment of patient perspectives using quality-of-life survey and utility analysis.
Joshi HB; Adams S; Obadeyi OO; Rao PN
Eur Urol; 2001 Jun; 39(6):695-701. PubMed ID: 11464060
[TBL] [Abstract][Full Text] [Related]
10. Intrathoracic ureteric stent migration through a reno-pleural fistula: a case report of rare antegrade ureteric stenting complication.
Chen YH; Chen M; Chen YH
BMC Womens Health; 2021 Jul; 21(1):270. PubMed ID: 34246259
[TBL] [Abstract][Full Text] [Related]
11. Role of percutaneous nephrostomy (PCN) in malignant ureteral obstruction.
Jalbani MH; Deenari RA; Dholia KR; Oad AK; Arbani IA
J Pak Med Assoc; 2010 Apr; 60(4):280-3. PubMed ID: 20419970
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study.
de Sousa Morais N; Pereira JP; Mota P; Carvalho-Dias E; Torres JN; Lima E
Urolithiasis; 2019 Dec; 47(6):567-573. PubMed ID: 30219938
[TBL] [Abstract][Full Text] [Related]
13. Survival time and period of catheterization in patients treated with percutaneous nephrostomy for urinary obstruction due to malignancy.
Radecka E; Magnusson M; Magnusson A
Acta Radiol; 2006 Apr; 47(3):328-31. PubMed ID: 16613316
[TBL] [Abstract][Full Text] [Related]
14. Ureteric stent versus percutaneous nephrostomy for acute ureteral obstruction - clinical outcome and quality of life: a bi-center prospective study.
Shoshany O; Erlich T; Golan S; Kleinmann N; Baniel J; Rosenzweig B; Eisner A; Mor Y; Ramon J; Winkler H; Lifshitz D
BMC Urol; 2019 Aug; 19(1):79. PubMed ID: 31455309
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous nephrostomy and antegrade ureteral stenting: technique-indications-complications.
Hausegger KA; Portugaller HR
Eur Radiol; 2006 Sep; 16(9):2016-30. PubMed ID: 16547709
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
[TBL] [Abstract][Full Text] [Related]
17. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
[TBL] [Abstract][Full Text] [Related]
18. The implications when offering percutaneous nephrostomy for the management of malignant obstructive uropathy secondary to urological malignancy: can we be more selective?
Osinibi E; Doan H; Mercado-Campero A; Abbaraju J; Masood S; Madaan S
Ther Adv Urol; 2023; 15():17562872231207729. PubMed ID: 37901283
[TBL] [Abstract][Full Text] [Related]
19. Comparison between Double J (DJ) Ureteral Stenting and Percutaneous Nephrostomy (PCN) in Obstructive Uropathy.
Ahmad I; Saeed Pansota M; Tariq M; Shahzad Saleem M; Ali Tabassum S; Hussain A
Pak J Med Sci; 2013 May; 29(3):725-9. PubMed ID: 24353616
[TBL] [Abstract][Full Text] [Related]
20. Management of obstructive calcular anuria with acute renal failure in children less than 4 years in age: a protocol for initial urinary drainage in relation to planned definitive stone management.
ElSheemy MS; Shoukry AI; Shouman AM; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA
J Pediatr Urol; 2014 Dec; 10(6):1126-32. PubMed ID: 24953544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
